Investors

We are an emerging, fully-integrated company focused on neurological diseases with a proven track record of turning this purpose into reality by combining expertise in development and commercialization with a passion for improving lives.

Latest quarterly results

News and events

Press releases

View all

Recent events

Stock information

ADMS